MASIMO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.5 USD | +0.53% |
|
+0.77% | +7.04% |
Financials (USD)
| Sales 2024 * | 2.1B | Sales 2025 * | 2.23B | Capitalization | 6.66B |
|---|---|---|---|---|---|
| Net income 2024 * | 99M | Net income 2025 * | 164M | EV / Sales 2024 * | 2.22 x |
| Net cash position 2024 * | 2B | Net cash position 2025 * | 1.74B | EV / Sales 2025 * | 2.21 x |
| P/E ratio 2024 * |
68.7
x | P/E ratio 2025 * |
42.1
x | Employees | 3,800 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.54% |
More Fundamentals
* Assessed data
More news
Latest transcript on Masimo Corporation
More recommendations
More press releases
More news
| 1 day | +0.53% | ||
| 1 week | +0.77% | ||
| Current month | +0.77% | ||
| 1 month | -7.75% | ||
| 3 months | -6.49% | ||
| 6 months | +17.82% | ||
| Current year | +7.04% |
1 week
114.46
131.02
1 month
112.85131.02
Current year
107.57153.93
1 year
75.22167.04
3 years
75.22305.21
5 years
75.22305.21
10 years
19.30305.21
| Managers | Title | Age | Since |
|---|---|---|---|
Joe Kiani
CEO | Chief Executive Officer | 59 | 89-04-30 |
Micah Young
DFI | Director of Finance/CFO | 45 | 17-10-15 |
Bilal Muhsin
COO | Chief Operating Officer | 43 | 99-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Craig Reynolds
BRD | Director/Board Member | 75 | 14-04-02 |
Joe Kiani
CEO | Chief Executive Officer | 59 | 89-04-30 |
Robert Chapek
BRD | Director/Board Member | 64 | 23-01-14 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.81% | 2 M€ | +9.08% | ||
| 0.45% | 7 M€ | +5.53% | ||
| 0.41% | 21 M€ | +8.41% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-07 | 125.5 | +0.53% | 486,716 |
| 24-06-06 | 124.8 | +0.14% | 1,002,677 |
| 24-06-05 | 124.6 | -4.15% | 1,221,083 |
| 24-06-04 | 130 | +1.38% | 818,011 |
| 24-06-03 | 128.2 | +3.01% | 1,133,605 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotes
Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The Company's measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry and advanced rainbow Pulse CO-Oximetry parameters. The Company's Non-healthcare business develops, manufactures, markets, sells home sound integration technologies and accessories, along with licensing complete high performance in-vehicle audio systems under consumer brands, such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology.
Calendar
2024-06-12
- Goldman Sachs Global Healthcare Conference
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
125.5
USD
Average target price
156.7
USD
Spread / Average Target
+24.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.04% | 6.66B | |
| -24.88% | 7.32B | |
| +15.10% | 5.5B | |
| -15.87% | 4.88B | |
| +14.96% | 4.1B | |
| -21.75% | 3.89B | |
| -25.03% | 2.83B | |
| +44.01% | 2.31B | |
| +1.98% | 2.07B | |
| +9.75% | 1.97B |
- Stock Market
- Equities
- MASI Stock
